McCann KE, Osman N, Cannon J, Brent L, et al. Goserelin 3-month depot shows non-inferiority to the monthly formulation in U.S. patients with premenopausal breast cancer: a real-world evidence study. Breast Cancer Res Treat 2025 Mar 6. doi: 10.1007/s10549-025-07656.
PMID: 40050524